In chronic lymphocytic leukaemia, tumour-derived EVs can also modulate PD-L1 expression in monocytes, creating a pro-inflammatory tumour microenvironment that facilitates immune escape [179]. The gene discussed is CD274; the disease is B-cell chronic lymphocytic leukemia.